Patents by Inventor Thomas Stoehr

Thomas Stoehr has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • THERAPEUTIC COMBINATION FOR PAINFUL MEDICAL CONDITIONS
    Publication number: 20120225119
    Abstract: An embodiment of the present invention relates to a therapeutic combination including (a) lacosamide and/or a pharmaceutically acceptable salt thereof; and (b) levetiracetam and/or a pharmaceutically acceptable salt thereof. The combination can be provided in a single dosage form or separate dosage forms.
    Type: Application
    Filed: April 9, 2012
    Publication date: September 6, 2012
    Applicant: UCB Pharma GmbH
    Inventors: Bettina Beyreuther, Thomas Stöhr
  • Methods for prophylaxis or treatment of conditions associated with cortical spreading depression
    Patent number: 8008351
    Abstract: The present invention is directed to the use of a class of peptide compounds for the prophylaxis and treatment of chronic headache, particularly migraines.
    Type: Grant
    Filed: April 15, 2005
    Date of Patent: August 30, 2011
    Assignee: UCB Pharma GmbH
    Inventors: Dieter Scheller, Thomas Stöhr
  • THERAPY FOR HYPEREXCITABILITY DISORDERS
    Publication number: 20100324144
    Abstract: The present invention is directed to the use of a class of peptide compounds for treating diseases associated with hyperexcitability. The present invention is also directed to the use of a class of peptide compounds for treating diseases associated with dysfunction of an ion channel.
    Type: Application
    Filed: June 29, 2007
    Publication date: December 23, 2010
    Applicant: SCHWARZ PHARMA AG
    Inventors: Cara Heers, Thomas Stoehr, Bettina Beyreuther
  • PEPTIDE COMPOUNDS FOR TREATING REFRACTORY STATUS EPILEPTICUS
    Publication number: 20100273714
    Abstract: The present invention is directed to the use of a class of peptide Compounds for prevention, alleviation or/and treatment of refractory Status epilepticus.
    Type: Application
    Filed: June 15, 2007
    Publication date: October 28, 2010
    Applicant: SCHWARZ PHARMA AG
    Inventor: Thomas Stoehr
  • Method for treating pain in trigeminal neuralgia
    Patent number: 7820857
    Abstract: The present invention is directed to the use of a class of peptide compounds for treating pain in trigeminal neuralgia.
    Type: Grant
    Filed: June 9, 2005
    Date of Patent: October 26, 2010
    Assignee: UCB Pharma GmbH
    Inventors: Thomas Stoehr, Christine Rauschkolb-Loeffler
  • COMPOUNDS FOR TREATING DEMYELINATION CONDITIONS
    Publication number: 20100260716
    Abstract: Therapeutic methods, therapeutic combinations and pharmaceutical compositions provided herein are useful for inhibiting demyelination, for delaying the clinical onset of a demylination condition, for inhibiting progression and/or reducing frequency of relapse of a demylination condition, and/or enhancing physical ability of a human subject having a demylination condition. Lacosamide is one of the active compounds.
    Type: Application
    Filed: October 23, 2008
    Publication date: October 14, 2010
    Applicant: UCB PHARMA GMBH
    Inventors: Thomas Stöhr, David Rudd
  • METHOD FOR TREATING ATYPICAL FACIAL PAIN
    Publication number: 20100256241
    Abstract: The present invention is directed to the use of a class of peptide compounds for treating pain in trigeminal neuralgia.
    Type: Application
    Filed: June 16, 2010
    Publication date: October 7, 2010
    Applicant: UCB PHARMA GMBH
    Inventors: Thomas Stoehr, Christine Rauschkolb-Loeffler
  • COMBINATION THERAPY FOR PAIN IN PAINFUL DIABETIC NEUROPATHY
    Publication number: 20100256179
    Abstract: A method for treating pain in painful diabetic neuropathy comprises administering in combination a first agent that comprises a compound as defined herein, illustratively lacosamide, and a second agent effective to provide enhanced treatment of pain, by comparison with the first agent alone. The second agent illustratively comprises an analgesic, an anticonvulsant, an antidepressant or an NMDA receptor antagonist.
    Type: Application
    Filed: April 1, 2010
    Publication date: October 7, 2010
    Applicant: UCB PHARMA GMBH
    Inventors: Thomas Stöhr, Bettina Beyreuther
  • ANTICONVULSANT COMBINATION THERAPY
    Publication number: 20100240576
    Abstract: The present invention is directed to a pharmaceutical composition comprising a Compound (a) of a class of peptide Compounds and at least one further Compound (b) for the prevention, alleviation or/and treatment of epileptic seizures.
    Type: Application
    Filed: June 15, 2007
    Publication date: September 23, 2010
    Inventor: Thomas Stoehr
  • Method for treating central neuropathic pain
    Patent number: 7794987
    Abstract: The present invention concerns the use of compounds for treating central neuropathic pain.
    Type: Grant
    Filed: December 2, 2004
    Date of Patent: September 14, 2010
    Assignee: UCB Pharma GmbH
    Inventor: Thomas Stoehr
  • Method for treating a motoneuron disorder
    Patent number: 7718161
    Abstract: The present invention is directed to the use of a class of peptide compounds for treating amyotrophic lateral sclerosis (ALS) and other forms of motoneuron diseases and peripheral neuropathies.
    Type: Grant
    Filed: September 18, 2008
    Date of Patent: May 18, 2010
    Assignee: UCB Pharma GmbH
    Inventor: Thomas Stoehr
  • METHODS FOR TREATING STATUS EPILEPTICUS AND RELATED CONDITIONS
    Publication number: 20090018197
    Abstract: The present invention is directed to the novel use of a class of peptide compounds for treating status epilepticus or related conditions, e.g. acute repetitive seizures, seizure clusters, etc.
    Type: Application
    Filed: August 8, 2008
    Publication date: January 15, 2009
    Inventors: David Rudd, Thomas Stoehr
  • Method for treating tremor
    Patent number: 7427601
    Abstract: The present invention is directed to the use of a class of peptide compounds for treating essential tremor and other tremor syndromes.
    Type: Grant
    Filed: June 10, 2005
    Date of Patent: September 23, 2008
    Assignee: Schwarz Pharma AG
    Inventor: Thomas Stoehr
  • Method for treating dyskinesia
    Patent number: 7416864
    Abstract: The present invention is directed to the use of a class of peptide compounds for treating primary or/and secondary dyskinesias such as tardive dyskinesia.
    Type: Grant
    Filed: May 16, 2005
    Date of Patent: August 26, 2008
    Assignee: Schwarz Pharma AG
    Inventor: Thomas Stoehr
  • Novel use of peptide compounds for treating pain in trigeminal neuralgia
    Publication number: 20060135437
    Abstract: The present invention is directed to the use of a class of peptide compounds for treating pain in trigeminal neuralgia.
    Type: Application
    Filed: June 9, 2005
    Publication date: June 22, 2006
    Applicant: SCHWARZ PHARMA AG
    Inventors: Thomas Stoehr, Christine Rauschkolb-Loeffler
  • Novel use of peptide compounds for treating status epilepticus or related conditions
    Publication number: 20060009384
    Abstract: The present invention is directed to the novel use of a class of peptide compounds for treating status epilepticus or related conditions, e.g. acute repetitive seizures, seizure clusters, etc.
    Type: Application
    Filed: December 3, 2004
    Publication date: January 12, 2006
    Inventors: David Rudd, Thomas Stoehr
  • Novel use of peptide compounds for treating central neuropathic pain
    Publication number: 20050209163
    Abstract: The present invention concerns the use of compounds for treating central neuropathic pain.
    Type: Application
    Filed: December 2, 2004
    Publication date: September 22, 2005
    Inventor: Thomas Stoehr